Ascentage Pharma Group International (AAPG) Current Deferred Tax Assets (2023 - 2025)
Historic Current Deferred Tax Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $93.4 million.
- Ascentage Pharma Group International's Current Deferred Tax Assets changed N/A to $93.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $93.4 million, marking a year-over-year change of. This contributed to the annual value of $42.1 million for FY2024, which is 2737.6% down from last year.
- Per Ascentage Pharma Group International's latest filing, its Current Deferred Tax Assets stood at $93.4 million for Q2 2025.
- In the past 5 years, Ascentage Pharma Group International's Current Deferred Tax Assets ranged from a high of $93.4 million in Q2 2025 and a low of $42.8 million during Q4 2024
- For the 3-year period, Ascentage Pharma Group International's Current Deferred Tax Assets averaged around $64.4 million, with its median value being $56.9 million (2023).
- Within the past 5 years, the most significant YoY rise in Ascentage Pharma Group International's Current Deferred Tax Assets was 2481.12% (2024), while the steepest drop was 2481.12% (2024).
- Ascentage Pharma Group International's Current Deferred Tax Assets (Quarter) stood at $56.9 million in 2023, then dropped by 24.81% to $42.8 million in 2024, then skyrocketed by 118.25% to $93.4 million in 2025.
- Its Current Deferred Tax Assets stands at $93.4 million for Q2 2025, versus $42.8 million for Q4 2024 and $56.9 million for Q4 2023.